Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Doungdean Tummanatsakun"'
Autor:
Son Dinh An Truong, Doungdean Tummanatsakun, Tanakorn Proungvitaya, Temduang Limpaiboon, Molin Wongwattanakul, Daraporn Chua-on, Sittiruk Roytrakul, Siriporn Proungvitaya
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1054 (2021)
The mortality rate of cholangiocarcinoma (CCA) is high since there is a lack of a non-invasive technique to accurately detect tumors at the early stage. CCA biomarkers are consistently needed for various purposes including screening, early diagnosis,
Externí odkaz:
https://doaj.org/article/4e1079c73a2d4c7b9466c66d7bce77cb
Autor:
Saeranee Siriphak, Ravinnipa Chanakankun, Tanakorn Proungvitaya, Sittiruk Roytrakul, Doungdean Tummanatsakun, Wunchana Seubwai, Molin Wongwattanakul, Siriporn Proungvitaya
Publikováno v:
Molecules, Vol 26, Iss 11, p 3105 (2021)
Cholangiocarcinoma (CCA) is a malignancy arising from cholangiocytes. Currently, the treatment and prognosis for CCA are mostly poor. Recently, we have reported that coiled-coil domain containing 25 (CCDC25) protein level in the sera may be a diagnos
Externí odkaz:
https://doaj.org/article/01c657af485344c0abbec292b350973e
Publikováno v:
Molecules, Vol 26, Iss 9, p 2587 (2021)
Apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) is involved in the DNA damage repair pathways and associates with the metastasis of several human cancers. However, the signaling pathway of APEX1 in cholangiocarcinoma (CCA) has never been report
Externí odkaz:
https://doaj.org/article/8538f258621c41f883798f38c1c9b00f
Autor:
Daraporn Chua-on, Tanakorn Proungvitaya, Doungdean Tummanatsakun, Anchalee Techasen, Temduang Limpaiboon, Sittiruk Roytrakul, Sopit Wongkham, Chaisiri Wongkham, Ongart Somintara, Sakkarn Sangkhamanon, Siriporn Proungvitaya
Publikováno v:
Biomolecules, Vol 10, Iss 7, p 1021 (2020)
Prognosis of cholangiocarcinoma (CCA) patients is absolutely poor. Since improvement of prognosis and/or response to treatment by personalized and precision treatments requires earlier and precise diagnostic markers, discovery of prognostic markers a
Externí odkaz:
https://doaj.org/article/d2fb0662bdfa4c9abdf99ccf6297ebea
Autor:
Doungdean Tummanatsakun, Tanakorn Proungvitaya, Sittiruk Roytrakul, Temduang Limpaiboon, Sopit Wongkham, Chaisiri Wongkham, Atit Silsirivanit, Ongart Somintara, Sakkarn Sangkhamanon, Siriporn Proungvitaya
Publikováno v:
Biomolecules, Vol 9, Iss 9, p 413 (2019)
Diagnostic and/or prognostic biomarkers for cholangiocarcinoma (CCA) are still insufficient with poor prognosis of patients. To discover a new CCA biomarker, we constructed our secretome database of three CCA cell lines and one control cholangiocyte
Externí odkaz:
https://doaj.org/article/8a94c36789c441c188baf68dbb9875e4
Autor:
Son Dinh An Truong, Molin Wongwattanakul, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Daraporn Chua-on, Doungdean Tummanatsakun, Siriporn Proungvitaya
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 13; Pages: 3826
Cholangiocarcinoma (CCA), a malignancy of the biliary epithelium, can arise at any point in the biliary system. We previously reported that CIAPIN1 is detectable in the sera and that its overexpression was associated with poor prognosis and metastasi
Autor:
DARAPORN CHUA-ON, TANAKORN PROUNGVITAYA, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, SITTIRUK ROYTRAKUL, DOUNGDEAN TUMMANATSAKUN, NORIE ARAKI, SIRIPORN PROUNGVITAYA
Publikováno v:
Cancer Genomics Proteomics
Background/Aim: We previously demonstrated that a mitochondrial protein, apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) is over-expressed in cholangiocarcinoma (CCA) and its serum levels can be a prognostic biomarker for CCA. To elucid
Autor:
Mang Ngaih Ciin, Tanakorn Proungvitaya, Temduang Limpaiboon, Sittiruk Roytrakul, Ubon Cha’on, Doungdean Tummanatsakun, Siriporn Proungvitaya
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 3 (2020)
Scopus-Elsevier
International Journal of Hematology-Oncology and Stem Cell Research, Vol 14, Iss 3 (2020)
Background: Cholangiocarcinoma (CCA) is the second most common primary hepatobiliary cancer. These patients have meager prognosis and short-term survival. Precise assessment of glomerular filtration rate is a fundamental aspect of clinical care in ca
Autor:
Temduang Limpaiboon, Sopit Wongkham, Anchalee Techasen, Tanakorn Proungvitaya, Daraporn Chua-On, Sakkarn Sangkhamanon, Chaisiri Wongkham, Siriporn Proungvitaya, Doungdean Tummanatsakun, Ongart Somintara, Sittiruk Roytrakul
Publikováno v:
Biomolecules
Volume 10
Issue 7
Biomolecules, Vol 10, Iss 1021, p 1021 (2020)
Volume 10
Issue 7
Biomolecules, Vol 10, Iss 1021, p 1021 (2020)
Prognosis of cholangiocarcinoma (CCA) patients is absolutely poor. Since improvement of prognosis and/or response to treatment by personalized and precision treatments requires earlier and precise diagnostic markers, discovery of prognostic markers a
Autor:
DARAPORN CHUA-ON, TANAKORN PROUNGVITAYA, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, SITTIRUK ROYTRAKUL, DOUNGDEAN TUMMANATSAKUN, NORIE ARAKI, SIRIPORN PROUNGVITAYA
Publikováno v:
Cancer Genomics & Proteomics (1109-6535); Jan/Feb2022, Vol. 19 Issue 1, p35-49, 15p